Navigation Links
Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
Date:11/28/2014

KANSAS CITY, Kan., Nov. 28, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced that it will present at the 26th Annual Piper Jaffray Healthcare Conference, to be held December 2-3, 2014, at the New York Palace Hotel in New York.

Steven St. Peter, M.D., President and Chief Executive Officer, will provide an overview of the Company's business during his live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.  Event:26th Annual Piper Jaffray Healthcare ConferenceDate: Wednesday, December 3, 2014 Time: 9:30 am (Eastern Time) Location:Rutherford, Track 5, The New York Palace HotelThe presentations will be webcast live and remain available for 30 days following the presentation.  To access the webcasts, please visit the investor relations section of the Aratana website at aratana.investorroom.com.

About Aratana TherapeuticsAratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The Company's pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions.  Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets.  For more information, please visit www.aratana.com.  

Contacts:
For investor inquires:
Aratana Therapeutics, Inc.
Craig Tooman
ctooman@aratana.com; (913) 353-1023

For media inquiries:
Tiberend Strategic Advisors, Inc.
Andrew Mielach
amielach@tiberend.com; (212) 375-2694


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana to Participate in Leerink Swanns November Management Access Days
2. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
3. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
4. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
5. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
6. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
7. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
8. Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
9. Aratana Therapeutics Drives Awareness of Pet Therapeutic Opportunity During "CVC Week" in Kansas City
10. Aratana Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
11. Aratana Therapeutics names Wendy Yarno to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... August 27, 2020 , ... Austin Oral Surgery – ... pleased to announce Dr. David Szalay, DDS, MD, has joined the practice. An accomplished ... the new Pflugerville office, which is scheduled to open this fall. The new office ...
(Date:8/27/2020)... ... 27, 2020 , ... Bridge To A Cure Foundation announces the appointment of ... pediatric neuro-oncologist who serves on the Board of Directors at The Preston Robert Tisch ... School. , Internationally recognized, Dr. Friedman is a widely published author of more than ...
(Date:8/26/2020)... Mo. (PRWEB) , ... August ... ... a member of Eurofins BioPharma Services, Laboratory Testing division, expands its technology ... existing suite of Flow Cytometry platforms available. With industry-leading biomarker solutions, complemented ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State University Global (CSU ... affordable online education – is proud to announce its new master’s degree in ... its kind in the nation, the 60-credit hour program is designed to provide ...
(Date:8/31/2020)... ... ... Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent time in the ... anxiety, immense stress, and right now are needing serious relief from a constant state of ... are experiencing a great degree of emotional discomfort, be it fear or worrying about their ...
(Date:8/31/2020)... HAVEN, Conn. (PRWEB) , ... August 31, 2020 ... ... medical device intended to improve outcomes for patients with advanced heart failure, today ... Research (SBIR) grant in the amount of $555,358 from the National Heart, Lung, ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... assist system designed to help treat patients with respiratory conditions, including COVID-19, while ... of helium and oxygen, but it captures exhaled gas and scrubs it free ...
(Date:8/28/2020)... ... 28, 2020 , ... Integrated Viral Protection (IVP Air) today announced ... deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is the first system ... to fully reopen equipped with the filtration system on September 8th. , The ...
Breaking Medicine News(10 mins):